Oak Harbor Wealth Partners LLC Boosts Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Oak Harbor Wealth Partners LLC boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 9.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,053 shares of the healthcare conglomerate’s stock after buying an additional 184 shares during the quarter. Oak Harbor Wealth Partners LLC’s holdings in UnitedHealth Group were worth $1,039,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of UNH. NewSquare Capital LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at about $25,000. AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at about $30,000. Promus Capital LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at about $32,000. RPg Family Wealth Advisory LLC acquired a new stake in shares of UnitedHealth Group during the 3rd quarter worth approximately $37,000. Finally, Legacy Investment Solutions LLC acquired a new stake in shares of UnitedHealth Group during the 3rd quarter worth approximately $57,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of recent analyst reports. Oppenheimer raised their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price for the company in a report on Friday, January 10th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Finally, Wells Fargo & Company decreased their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $493.35 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a market capitalization of $451.28 billion, a P/E ratio of 31.83, a P/E/G ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company’s fifty day moving average price is $513.78 and its 200 day moving average price is $553.76.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s revenue was up 6.8% compared to the same quarter last year. During the same quarter last year, the firm earned $5.83 earnings per share. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be issued a $2.10 dividend. The ex-dividend date is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.70%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.